Liver Biology, Diseases & Cancer

Time:November 04-08, 2017

Country&Region: China Mainland

Venue:suzhou

Organizer:Gen-Sheng Feng, University of California, San Diego, USA Lijian Hui, Shanghai Institute for Biologic

  • Share on Facebook
  • Tweet
  • Post to Tumblr
  • Pin it
  • Add to Pocket
  • Submit to Reddit
  • Share on LinkedIn
  • Publish on WordPress
  • Save to Pinboard
  • Send email

We are pleased to announce the 4th Cold Spring Harbor Asia conference on Liver Biology, Disease & Cancer which will be held in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday December 4, and will conclude after lunch on December 8, 2017.

The conference will include eight oral sessions and one poster session covering the latest findings across many topics in basic, translational & clinical liver research. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.
 

Major Topics:
1. Liver Progenitor Cells and iPS Cells 
2. Hepatic Cell Fate Determination and Lineage Tracing
3. Liver Injuries, Repair and Treatment
4. Alcoholic and Non-Alcoholic Steatohepatitis
5. Hepatic Fibrogenesis and Therapeutics
6. Hepatocarcinogenesis and Novel Therapy
7. Immunotherapy for Liver Cancer
 

Keynote Speakers:
Lieping Chen, Yale University School of Medicine, USA
Inder Verma, The Salk Institute, USA 

Invited Speakers:
Fan Bai, Peking university, China
Rene Bernards, Netherlands Cancer Institute, THE NETHERLANDS
David Brenner, University of California, San Diego, USA
Xin Chen, University of California, San Francisco, USA
Gen-Sheng Feng, University of California, San Diego, USA
Markus Grompe, Oregon Health and Sciences University, USA
Tim Greten, National Cancer Institute, USA
Xin-Yuan Guan, The University of Hong Kong, CHINA
Mathias Heikenwälder, Technische Universitat Munchen, GERMANY
Lijian Hui, Shanghai Institute for Biological Sciences, CHINA
Tom Lüdde, University Hospital RWTH Aachen, GERMANY
Atsushi Miyajima, University of Tokyo, JAPAN
David Moore, Baylor College of Medicine, USA
Takahiro Ochiya, National Cancer Center Research Institute, JAPAN
Eli Pikarsky, The Hebrew University of Jerusalem, ISRAEL
Shuji Terai, Niigata University, JAPAN
Fu-sheng Wang, Beijing 302 Hospital, CHINA
Xin Wei Wang, National Institute of Health, USA
Yunfang Wang, Beijing Institute of Transfusion Medicine, CHINA
Wei-Fen Xie, Changzheng Hospital, Second Military Medical University, CHINA
Shiou-Hwei Yeh, National Taiwan University College of Medicine, TAIWAN
Victor Yu, National University of Singapore, SINGAPORE
Lars Zender, University Hospital Tuebingen, GERMANY
Bin Zhou, Shanghai Institutes for Biological Sciences, CAS, CHINA
Jian Zhou, Zhongshan Hospital, Fudan Unviersity, CHINA
Jessica Zucman-Rossi, INSERM U674, FRANCE

 

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers. 


Fellowship: 
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $100-$500) awards. For more details, please visit http://www.csh-asia.org/stipends.html

We look forward to seeing you at Suzhou in December, 2017.

PharmaSources Customer Service